A randomized, placebo-controlled, double-blind, parallel-group trial of observations of subjective and objective symptoms of eye fatigue and testing for improvement with the ingestion of bilberry extract
- Conditions
- Healthy subjects
- Registration Number
- JPRN-UMIN000035908
- Lead Sponsor
- HUMA R&D CORP
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 37
Not provided
1) Patients who are currently receiving any medications or outpatient 2) Subjects currently undergoing exercise or diet therapy under the supervision of a physician 3) Persons with a history or current disease or complication of liver disease or serious diseases of renal, endocrine, cardiovascular, gastrointestinal, pulmonary, hematological, or metabolic origin. 4) Persons who have been treated or had a history of chronic disease (arrhythmia, liver, kidney, cerebrovascular disease, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or other chronic diseases) 5) Persons who have had surgery of the digestive tract (appendicitis is allowed) 6) People who have pollinosis 7) Patients with ocular diseases other than refractive errors (hyperopia, myopia, astigmatism) 8) Persons with a history of drug allergy or food allergy 9) Those who wish to do so during pregnancy, lactation, or the study period. 10) Those who have received blood donations or vaccinations within the previous three months or who are scheduled to do so during the study period. 11) Persons who regularly consume health foods, supplements, and medicines that may affect eye function. 12) Persons who are in hospital due to mental disorders (depression etc.), sleeping disorders, etc., or who have a past medical history in the past. 13) Persons who are under treatment or have a history of alcohol dependence, drug dependence or drug abuser. 14) Person who is in shift work such as night work 15) Extremely irregular lifestyle, such as eating and sleeping 16) Current smokers 17) Subjects who have participated in other clinical trials or are currently participating in other clinical trials within the past 3 months of the date of informed consent. 18) Persons who have difficulty complying with the records of various surveys 19) Other persons for whom the principal investigator judges it inappropriate for the study. "
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method